Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-17.54%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-17.54%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-368.03%
20%
—
—
Never
—
5 Years
Score—
Net Growth-368.03%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Edgewise Therapeutics Inc fundamental performance
Across Edgewise Therapeutics Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 42M to -$ 167M. Revenue increased in 0% of the years measured; net income in 20%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 43.56 | — |
1 Year2025-08-12 | $ 13.39 | 225.32% |
5 Years2021-08-12 | $ 17.69 | 146.24% |
All Time2021-03-26 | $ 30.00 | 45.20% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-03-26 |
|---|---|---|---|---|
| Price | $ 43.56 | $ 13.39 | $ 17.69 | $ 30.00 |
| Return | — | 225.32% | 146.24% | 45.20% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 197M | $ 460M |
| 2025 | $ 0.00 | -$ 167M | $ 530M |
| 2024 | $ 0.00 | -$ 133M | $ 470M |
| 2023 | $ 0.00 | -$ 100M | $ 318M |
| 2022 | $ 0.00 | -$ 15M | $ 351M |
| IPO2021 | $ 0.00 | -$ 42M | $ 280M |
Explore beyond EWTX
You're looking at Edgewise Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
